Building control arms for cancer clinical trials from real-world data Published June 2019 Citation Bennette, CS, Segal, BD, Miksad, RA, Bellomo, L, Nussbaum, NC, Sarkar, S, Tucker, MG, Abernethy, AP. . HTAi. . https://htai.org/wp-content/uploads/2019/08/htai_AM19_abstracts_20190812.pdf#page=14 Authors:Bennette, CS, Segal, BD, Miksad, RA, Bellomo, L, Nussbaum, NC, Sarkar, S, Tucker, MG, Abernethy, AP Sources:HTAi Share Posted inPublicationsMethodology More publicationsISPORApril 2026Evaluating model performance for between-country survival transportabilityAli MS, Pittell H, Horne E, Mpofu P, Zhang Q, Adamson B, et al.Publication summaryPublicationsMethodologyMultiple myelomaISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerISPORApril 2026Impact of telemedicine encounters on survival outcomes in advanced lung cancer: A time-varying cox analysis using EHR-derived dataParatane D, Adamson B, Zemplenyi APublication summaryPublicationsNon-small cell lung cancer